INX IMCD N.V.

Shareholders meeting IMCD N.V. adopts all resolutions

Shareholders meeting IMCD N.V. adopts all resolutions

ROTTERDAM, The Netherlands (30 June 2020) – IMCD N.V. (hereafter “IMCD” or the “Company”) announces that all resolutions proposed to the shareholders at the Company’s Annual General Meeting (“AGM”) held today were adopted. This includes the adoption of the financial statements for the year 2019 and approval of the dividend proposal of EUR 0.90 per share in cash. The dividend calendar is as follows:

Thursday 2 July 2020 - Ex-dividend date

Friday 3 July 2020 - Record date

Monday 6 July 2020 - Payment date



Please find attached the full press release.



Attachment

EN
30/06/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IMCD N.V.

 PRESS RELEASE

IMCD publishes convocation for its upcoming AGM

IMCD publishes convocation for its upcoming AGM Rotterdam, the Netherlands (19 March 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today published the convocation and agenda for its Annual General Meeting of Shareholders (AGM), which will be held on Thursday 30 April 2026 at 10:30 CEST at the Company’s offices at Wilhelminaplein 32, 3072 DE Rotterdam, the Netherlands. The convocation, agenda and further documentation for the AGM are available in the of IMCD’s website. The meeting will be held...

 PRESS RELEASE

IMCD releases 2025 Annual Report

IMCD releases 2025 Annual Report Rotterdam, the Netherlands (4 March 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today releases its 2025 Annual Report. The report offers the Company’s stakeholders a comprehensive view of IMCD’s performance in 2025. The full annual report is available in the of the Company’s website. Financial calendar:4 March 2026                Annual report 202530 April 2026                 First three months 2026 results30 April 2026                 Annual General Meeti...

 PRESS RELEASE

IMCD nominates Andreas Igerl as CCO and member of the Management Board

IMCD nominates Andreas Igerl as CCO and member of the Management Board Rotterdam, the Netherlands (4 March 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, is pleased to announce that its Supervisory Board nominates Andreas Igerl to become Chief Commercial Officer (CCO) and member of the Management Board. Andreas Igerl, in his role as CCO, will strengthen the Management Board with his international experience and will further drive commercial excellence within IMCD. In addition, he will continue ...

 PRESS RELEASE

IMCD nominates Ruud Joosten as Supervisory Board member

IMCD nominates Ruud Joosten as Supervisory Board member Rotterdam, the Netherlands (4 March 2026) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, is pleased to announce that its Supervisory Board nominates Ruud Joosten as member of the Supervisory Board. Ruud Joosten is the CEO of Royal BAM Group NV since 2020 and is a non-executive board member at Altana AG since 2024. He started his career at Sigma Coatings (currently PPG) in 1988. He joined AkzoNobel in 1996 where he held several management roles a...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ahold Delhaize: Peer Walmart 4Q25/26 results. Arcadis: Main topics 4Q25/FY25 conference call. ASM: 4Q25 preview, FY26 should be strong. Brunel: 4Q25 result beats and trends stabilise; DACH back to growth in 1Q26; additional cost savings announced and special dividend. Cofinimmo: Beat on bottom line, strong investment outlook for 2026. IMCD: Another step in EMEA. Magnum Ice Cream Company: Peer Danone 4Q25 results. Recticel: Peer Kingspan FY25 results. Software sector: Cheaper code...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch